HMRI is providing proactive logistical support to healthcare staff working at the coronavirus coalface, through its partnership with HNE Health.
Author: Marlin Admin
Repurposing drugs for ovarian cancer
Associate Professor Nikola Bowden, Professor Jennifer Martin, Dr Michelle Wong-Brown and Dr Penny Reeves from the University of Newcastle and the Hunter Medical Research Institute have successfully been awarded $2.69 million for their Australian Program for Drug-repurposing for Treatment-resistant Ovarian Cancer.
Hunter researchers seeking locals who have tested positive with COVID-19
Professor Peter Wark is working with a team at the Hunter Medical Research Institute on a study to assess how the immune system responds to COVID-19.
Hunter Researchers Awarded Competitive Cardiovascular Grants
Over $20 million in funding has been awarded to NSW cardiovascular researchers, with HMRI affiliated researchers to share in the funds.
Coping with trauma and anxiety during COVID-19
The bushfires, floods and now the COVID-19 pandemic have had an ongoing impact on many people’s anxiety levels for months. For many Australians, this has had a cumulative impact on their mental health and wellbeing. In situations like this, our minds are responding to a perceived threat has been continuing for months.
The impact of COVID-19 on people with cardiovascular disease and other chronic illnesses
We spoke with HMRI Cardio-oncologist Professor Aaron Sverdlov about why people with chronic conditions, such as cardiovascular disease, cancer and diabetes, are at greater risk from COVID-19.
HMRI leading a coordinated approach to clinical trials on COVID-19
The Hunter Medical Research Institute (HMRI) Clinical Trials Unit is playing a key role in supporting a major nationwide study testing potential treatments for coronavirus, COVID-19.
Clinical trial to repurpose existing drugs for COVID-19 treatments
HMRI is delighted to be involved in a new clinical trial aimed at testing the safety and efficacy of existing drugs for patients hospitalised with COVID-19.
A new treatment approach for bowel cancer
Professor Xu Dong Zhang has discovered a molecule in late-stage bowel cancer that typically resists treatment.
Hand sanitisers and COVID-19
Jessica Stokes-Parish explains what we need to look for in a hand sanitiser.
